Latest Stock Market News

Microcap stocks with strong mutual fund ownership are surging in FY26, with 13 names up 70–150% and five already delivering multibagger returns.

The dollar swung between gains and losses against major peers as investors awaited key U.S. economic data and commentary from Federal Reserve officials to gauge the U.S. monetary policy path

Jason Samuel, Founder of House of Swamiraj, said these two projects will be smart homes with use of latest technologies.

The company has bought 462 units in Aspire Leisure Valley project for Rs 696.20 crore and 147 units in Aspire Centurian Park project for Rs 373.23 crore

Microcap stocks with strong mutual fund ownership are surging in FY26, with 13 names up 70–150% and five already delivering multibagger returns.

Indian stock markets rallied strongly on Wednesday, with both Sensex and Nifty recovering from early dips. A surge in foreign investment and a comeback by key IT companies bolstered investor confidence. Infosys spearheaded the gains, anticipating its substantial share buyback program commencing Thursday. This positive momentum signals a strengthening market sentiment.

India’s markets may be nearing the end of a 14-month consolidation cycle, with JM Financial’s Ankur Jhaveri predicting stronger earnings in FY27 and broader market participation ahead. Speaking at India Xchange 2025, he highlights opportunities in autos, data centres, EMS, healthcare, value retail and BFSI, while noting improving consumption trends and rising investor optimism.

Sammaan Capital shares dropped sharply after the Supreme Court ordered the CBI to file an FIR. The court criticized the CBI and Ministry of Corporate Affairs for a friendly approach . SEBI s reluctance to probe was also questioned. The ED will hold a joint meeting with other agencies. Sammaan Capital stated regulators found no wrongdoing in past examinations.

Public sector banks are rallying, sparking debate on their valuations compared to private lenders. Rahul Arora sees opportunities, especially in SBI and Bank of Baroda. He notes a significant valuation gap remains, suggesting further upside potential for PSU banks. Private banks face growth limitations due to large balance sheets. Global fund flows could favor banks if capital returns to India.

Sudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price band for the offer is set at Rs 563–593, with 50% of shares reserved for QIBs, 15% for NIIs and 35% for retail investors. With a GMP hovering around 16% ahead of the launch, the IPO is generating significant buzz in the unlisted market.